PTC518
PTC518-CNS-002-HD
Phase 2 small_molecule completed
Quick answer
PTC518 for Huntington Disease is a Phase 2 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- Huntington Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed